English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52584909    線上人數 :  675
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lin c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 86-95 / 3227 (共323頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-08-19T00:20:54Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S.
臺大學術典藏 2022-08-12T06:29:23Z Splenic abscess: A case report Wu T.-Y.; KING-JEN CHANG; Lin C.-H.; Lee J.-S.; Tsay Y.-W.
臺大學術典藏 2022-08-12T06:28:02Z The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Huang C.-S.; Kuo S.-H.; Lien H.-C.; Yang S.-Y.; You S.-L.; Shen C.-Y.; Lin C.-H.; Lu Y.-S.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:27:57Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; KING-JEN CHANG; Cheng A.-L.
臺大學術典藏 2022-08-12T06:27:56Z Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; Cheng A.-L.; KING-JEN CHANG; Huang C.-S.
臺大學術典藏 2022-08-12T06:27:55Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; KING-JEN CHANG; Lin C.-H.; Cheng A.-L.
臺大學術典藏 2022-08-12T06:27:49Z The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer Wang J.; Shih T.T.F.; Yen R.-F.; Lu Y.-S.; Chen C.-Y.; Mao T.-L.; Lin C.-H.; Kuo W.-H.; Tsai Y.-S.; KING-JEN CHANG; Chien K.-L.
臺大學術典藏 2022-08-12T06:27:47Z Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; KING-JEN CHANG; Cheng A.-L.
臺大學術典藏 2022-08-12T06:27:43Z Safety and efficacy of Tien-Hsien Liquid Practical in patients with refractory metastatic breast cancer: A randomized, double-blind, placebo-controlled, parallel-group, phase IIa trial Kuo W.-H.; Yao C.-A.; Lin C.H.; KING-JEN CHANG
臺大學術典藏 2022-08-12T06:27:39Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; KING-JEN CHANG; Huang C.-S.

顯示項目 86-95 / 3227 (共323頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目